Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Association of circulating progenitor cells with angiotensin II in newly diagnosed hypertensive patients

Journal of Human Hypertension volume 32, pages 46–53 (2018)Cite this article

Subjects

Abstract

Populations of CD34− and VEGFR2-expressing cells are responsible for regeneration of damaged endothelium and vascular remodelling. As their quantity and activity changes during cardiovascular diseases, they are potentially useful markers of cardiovascular health. The aim of our study was to investigate changes of various CD34+ and CD34+ VEGFR2+ populations in subjects with newly recognised hypertension and to evaluate whether observed alterations are influenced by clinical parameters and angiotensin II. Circulating CD34+ and CD34+ VEGFR2+ cells were analysed in peripheral blood samples by flow cytometry. Serum levels of angiotensin II were determined using immunoenzymatic assay. We discovered increased proportions of various CD34+ populations and CD34+ VEGFR2+ c-Kit+ cells in newly diagnosed patients. CD34+ cells seem to be influenced by angiotensin II, but we did not observe comparable results when populations co-expressing VEGFR2 were analysed. The quantity of CD34+ VEGFR2+ cells in patients with newly recognised primary hypertension ought to be determined by other factors. Increased proportions of CD34+ progenitors in blood could comprise compensatory mechanism for increased endothelial damage in hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Van Zonneveld AJ, Rabelink TJ. Endothelial progenitor cells: biology and therapeutic potential in hypertension. Curr Opin Nephrol Hypertens. 2006;15:167–72.

    Article  Google Scholar 

  2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;14:964–7.

    Article  Google Scholar 

  3. Caiado F, Dias S. Endothelial progenitor cells and integrins: adhesive needs. Fibrogenesis Tissue Repair. 2012;5:4.

    Article  CAS  Google Scholar 

  4. Lennartsson J, Ronnstrand L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev. 2012;92:1619–49.

    Article  CAS  Google Scholar 

  5. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430–6.

    Article  CAS  Google Scholar 

  6. Girbl T, Lunzer V, Greil R, Namberger K, Hartmann TN. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte-colony-stimulating factor. Transfusion. 2014;54:2325–35.

    Article  CAS  Google Scholar 

  7. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol. 2009;29:1802–9.

    Article  CAS  Google Scholar 

  8. Emdin M, Fatini C, Mirizzi G, Poletti R, Borrelli C, Prontera C, et al. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? Clin Chim Acta. 2015;443:85–93.

    Article  CAS  Google Scholar 

  9. Kokot F, Ficek R. Role of the renin-angiotensjon-aldosterone system in the pathogenesis of arterial hypertension. Postępy Nauk Med. 2002;15:117–112.

    Google Scholar 

  10. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the Management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.

    Article  Google Scholar 

  11. Skrzypkowska M, Myśliwska J, Słomiński B, Siebert J, Gutknecht P, Ryba-Stanisławowska M. Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients. J Hum Hypertens. 2015;29:324–30.

    Article  CAS  Google Scholar 

  12. Mackie A, Losordo D. CD34-Positive stem cells in the treatment of heart and vascular disease in human beings. Tex Heart Inst J. 2011;38:474–85.

    PubMed  PubMed Central  Google Scholar 

  13. Mandraffino G, Imbalzano E, Sardo MA, D’Ascola A, Mamone F, Lo Gullo A, et al. Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement. J H Hyperten. 2014;28:543–50.

    Article  CAS  Google Scholar 

  14. Marketou ME, Kalyva A, Parthenakis FI, Pontikoglou C, Maragkoudakis S, Kontaraki JE. Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness. J Clin Hypertens. 2014;16:295–300.

    Article  CAS  Google Scholar 

  15. Kim SY, Park SY, Kim JM, Kim JW, Kim MY, Yang JH, et al. Differentiation of endothelial cells from human umbilical cord blood AC133-CD14+ cells. Ann Hematol. 2005;84:417–22.

    Article  CAS  Google Scholar 

  16. Zhang Y, Foudi A, Geay JF, Berthebaud M, Buet D, Jarrier P, et al. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells. 2004;22:1015–29.

    Article  CAS  Google Scholar 

  17. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:1–7.

    Article  Google Scholar 

  18. Lee CW, Huang PH, Huang SS, Leu HB, Huang CC, Wu TC, et al. Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy. Hypertens Res. 2011;34:999–1003.

    Article  CAS  Google Scholar 

  19. Zhong HL, Lu XZ, Chen XM, Yang XH, Zhang HF, Zhou L, et al. Relationship between stem cell factor/c-kit expression in peripheral blood and blood pressure. J H Hypertens. 2010;24:220–5.

    Article  CAS  Google Scholar 

  20. Rodgers KE, Xiong S, Steer R, Dizerega GS. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells. 2000;18:287–94.

    Article  CAS  Google Scholar 

  21. Yin T, Ma X, Zhao L, Cheng K, Wang H. Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Res. 2008;18:792–9.

    Article  CAS  Google Scholar 

  22. Brunet de la Grange P, Ivanovic Z, Leprivey-Lorgeot V, Praloran V. Angiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented medium. Stem Cells. 2002;20:269–71.

    Article  CAS  Google Scholar 

  23. Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, deGasparo M. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension. 2002;39:830–5.

    Article  CAS  Google Scholar 

  24. Roks AJ. Angiotensin II deteriorates endothelial progenitor cells: good intentions with bad consequences. Hypertension. 2011;58:356–8.

    Article  Google Scholar 

  25. Zhu XY, Urbieta Caceres VH, Favreau FD, Krier JD, Lerman A, Lerman LO. Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration. J Hypertens. 2011;29:1972–9.

    Article  CAS  Google Scholar 

  26. Mandraffino G, Aragona CO, Cairo V, Scuruchi M, Lo Gullo A, D’Ascola A, et al. Circulating progenitor cells in hypertensive subjects: Effectiveness of treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacologicaleffects. PLoS ONE. 2017;12:e0173030.

    Article  Google Scholar 

  27. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403–9.

    Article  CAS  Google Scholar 

  28. Yamada T, Kondo T, Numaguchi Y, Tsuzuki M, Matsubara T, Manabe I, et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol. 2007;27:2363–9.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The paper was subsided by the grants of National Science Centre Nr 2011/01/B/NZ5/00345. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Immunology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1, 80-210, Gdańsk, Poland

    Maria W. Skrzypkowska, Monika E. Ryba-Stanisławowska, Bartosz Słomiński & Jolanta M. Myśliwska

  2. University Center for Cardiology Department of Family Medicine, Medical University of Gdansk, M. Skłodowskiej-Curie 3a, 80-210, Gdańsk, Poland

    Piotr G. Gutknecht & Janusz Siebert

Authors
  1. Maria W. Skrzypkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monika E. Ryba-Stanisławowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bartosz Słomiński
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Piotr G. Gutknecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Janusz Siebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jolanta M. Myśliwska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria W. Skrzypkowska.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Skrzypkowska, M., Ryba-Stanisławowska, M.E., Słomiński, B. et al. Association of circulating progenitor cells with angiotensin II in newly diagnosed hypertensive patients. J Hum Hypertens 32, 46–53 (2018). https://doi.org/10.1038/s41371-017-0020-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-017-0020-3

Search

Advanced search

Quick links